etrials and Quintiles Sign Strategic Technology Partnership and Licensing Deal
In a collaborative effort designed to increase the speed and efficiency of late-phase clinical research, etrials Worldwide, Inc. and Quintiles Transnational Corp. today announced that they have entered into an arrangement to license etrials’ eClinical Suite of software and to collaborate to develop technology specifically for use in peri-approval studies.
etrials is a leading provider of eClinical software for the efficient collection, cleaning, integration and review of data in the clinical trial process. Quintiles Transnational is the world’s leading provider of services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries.
As part of the arrangement, etrials will augment its existing eClinical Suite by developing a new Phase IV product offering to take advantage of the valuable data collected in late-stage and post-approval trials. The new products will combine Quintiles’ expertise in the post-approval market, including certain technology transferred to etrials, and etrials’ best-in-class technology.
“This partnership will further diversify the technologies Quintiles offers our clients with etrials’ fully integrated electronic data capture and interactive voice response technologies,” said Dr. Hugo Stephenson, president of Strategic Research Services for Quintiles. “Building on our expertise and experience in data management, our strategic investment in the development of a clinical trial management system and Phase IV specific tools will be a great asset to our clients.”
The three-year licensing agreement provides Quintiles’ clients with etrials’ fully integrated suite of eClinical tools for use in late-phase studies, including electronic data capture; interactive voice response; and reporting/analytic tools. The contract also provides etrials with backlog and ongoing work relating to ten late-phase clinical trials already in progress that will be supported by etrials.
“With the pharmaceutical and biotechnology industries experiencing a shift in focus to dynamic trials and safety, partnering with Quintiles is an exciting opportunity to provide a wider base of clinical researchers with the integral data they need to make the best decisions,” said John Cline, CEO of etrials. “Quintiles and etrials share the common vision of making clinical research easier for our valued clients. Together, we are eager to provide those benefits to our global partners.”
About Quintiles Transnational Corp.
Quintiles helps improve healthcare worldwide by providing a broad range of professional services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. Headquartered near Research Triangle Park, North Carolina, Quintiles has offices in 50 countries and is the world’s leading pharmaceutical services organization. For more information visit the company’s Web site at <a target='_blank' href='http://www.quintiles.com.
About etrials Worldwide, Inc.
etrials is a software and services company dedicated to making eClinical easy. We are the first company to offer a fully integrated suite of eClinical software including electronic data capture (EDC), electronic patient reported outcomes (ePRO), interactive voice response (IVR) and analytics to support the entire clinical trial process, from collection and cleaning to the integration and review of data. Our expertise includes studies from Phase I to post-approval for pharmaceutical, biotechnology and clinical research organizations. To date, our team of professionals has participated in over 450 clinical trials in more than 50 different countries.
etrials makes easy-to-use technologies supported by people who are just as easy to work with. Visit us at www.etrials.com .
